Protein-Protein Interaction Analysis of Corticotropin - Releasing Hormone Receptor 1 with Corticotropin-Releasing Hormone and Sauvagine

다국어 초록 (Multilingual Abstract)

Corticotropin - releasing hormone receptor 1 (CRHR1) forms an integral part of the pathophysiology of disorders like post-traumatic stress disorder, stress, anxiety, addiction, and depression. Hence it is essential to look for new, potent and structure-specific inhibitors of CRHR1. We have analysed the protein-protein interaction complexes of the CRHR1 receptor with its native ligand CRF and full agonist Sauvagine. The structure of Sauvagine was predicted using homology modelling. We have identified that the residues TYR253, ASP254, GLU256, GLY265, ARG1014 and LY1060 are important in the formation of protein-protein complex formation. Future studies on these residues could throw light on the crucial structural features required for the formation of CRHR1-inhibitor complex and in studies that try to solve the structural complexities of CRHR1.

참고문헌 (Reference)

1 C. Colovos, "Verification of protein structures: patterns of nonbonded atomic inter-actions" 2 : 1511-1519, 1993

2 E. M. Jutkiewicz, "The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adre- nocorticotropin in rats" 180 : 215-223, 2005

3 S. C. Lovell, "Structure validation by Ca geometry: f, y and Cb deviation" 50 : 437-450, 2003

4 Santhosh Kumar Nagarajan, "Protein–Protein Interaction Analysis of KiSS1–Derived Peptide Receptor with Kisspeptin–10 and Kisspeptin–15" 기초과학연구원 11 (11): 9-13, 2018

5 M. Wiederstein, "ProSA-web: inter- active web service for the recognition of errors in three-dimensional structures of proteins" 35 : W407-W410, 2007

6 D. Kozakov, "PIPER: An FFT-based protein docking program with pairwise potentials" 65 : 392-406, 2006

7 V. Coric, "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder" 27 : 417-425, 2010

8 Y. Shen, "Improved PEP-FOLD approach for peptide and miniprotein structure prediction" 10 : 4745-4758, 2014

9 N. Sato, "Immunolocalization of corti-cotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial car-cinoma: CRHR1 as a potent prognostic factor" 24 : 1549-1557, 2014

10 D. Kozakov, "How good is automated protein docking?" 81 : 2159-2166, 2013

11 Sathya Babu, "Hologram Based QSAR Analysis of Xanthine Oxidase Inhibitors" 기초과학연구원 10 (10): 202-208, 2017

12 M. F. Lensink, "Docking, scoring, and affinity prediction in CAPRI" 81 : 2082-2095, 2013

13 R. L. Hauger, "Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands" 55 : 21-26, 2003

14 F. C. Raadsheer, "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression" 152 : 1372-1376, 1995

15 F. Stamatelou, "Corticotropin-releasing hormone and progesterone plasma levels association with the onset and progression of labor" 2013

16 R. Pastor, "Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism" 105 : 9070-9075, 2008

17 H.-B. Fan, "Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord" 36 : 9559-9565, 2015

18 Santhosh Kumar Nagarajan, "Comparative Molecular Similarity Indices Analysis (CoMSIA) of 8-substituted-2-aryl-5-alkylaminoquinolines as Corticotropin-releasing factor-1 Receptor Antagonists" 기초과학연구원 9 (9): 241-248, 2016

19 S. R. Comeau, "ClusPro: an automated docking and dis- crimination method for the prediction of protein complexes" 20 : 45-50, 2003

20 S. C. Comeau, "ClusPro: a fully automated algorithm for protein-protein docking" 32 : 96-99, 2004

21 B. P. Grone, "A second corticotropin-releasing hormone gene (CRH2) is conserved across vertebrate classes and expressed in the hindbrain of a basal neopterygian fish, the spotted gar" 523 : 2015-, 2015

22 B. Binneman, "A 6-week randomized, placebo-con- trolled trial of CP-316,311 (a selective CRH1 antag- onist) in the treatment of major depression" 165 : 617-620, 2008

23 Santhosh Kumar Nagarajan, "3D-QSAR Studies of 8-Substituted-2-aryl-5-alkylaminoquinolines as Corticotropin-releasing Factor-1 Receptor Antagonists" 기초과학연구원 8 (8): 176-183, 2015